The International Agency for Research on Cancer has justified its advice that scientists should not publish preliminary material from a high-profile assessment of the safety of the weedkiller glyphosate, following a media investigation.
In April, the IARC told members of its glyphosate working group that it did not believe they should release preliminary or deliberative drafts relating to the glyphosate assessment.
An investigation by the news agency Reuters reported on 25 October that the IARC said that it was the “sole owner” of the material, and that it should not be published. The article quoted strong criticism of the advice by the agricultural biotechnology company Monsanto’s vice president of strategy Scott Partridge, who said: “The public deserves a process that is guided by sound science, not IARC’s secret agendas.”
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.